These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

2777 related articles for article (PubMed ID: 31341276)

  • 1. Intercellular interaction dictates cancer cell ferroptosis via NF2-YAP signalling.
    Wu J; Minikes AM; Gao M; Bian H; Li Y; Stockwell BR; Chen ZN; Jiang X
    Nature; 2019 Aug; 572(7769):402-406. PubMed ID: 31341276
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Statin suppresses Hippo pathway-inactivated malignant mesothelioma cells and blocks the YAP/CD44 growth stimulatory axis.
    Tanaka K; Osada H; Murakami-Tonami Y; Horio Y; Hida T; Sekido Y
    Cancer Lett; 2017 Jan; 385():215-224. PubMed ID: 27773750
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LIM-domain protein AJUBA suppresses malignant mesothelioma cell proliferation via Hippo signaling cascade.
    Tanaka I; Osada H; Fujii M; Fukatsu A; Hida T; Horio Y; Kondo Y; Sato A; Hasegawa Y; Tsujimura T; Sekido Y
    Oncogene; 2015 Jan; 34(1):73-83. PubMed ID: 24336325
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oncogenic Activation of YAP Signaling Sensitizes Ferroptosis of Hepatocellular Carcinoma
    Qin Y; Pei Z; Feng Z; Lin P; Wang S; Li Y; Huo F; Wang Q; Wang Z; Chen ZN; Wu J; Wang YF
    Front Cell Dev Biol; 2021; 9():751593. PubMed ID: 34977009
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hippo pathway inactivation through subcellular localization of NF2/merlin in outer cells of mouse embryos.
    Goda N; Ito Y; Saito S; Suzuki M; Bai H; Takahashi M; Wakai T; Kawahara M
    Development; 2024 Jul; 151(14):. PubMed ID: 39077779
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Merlin/NF2 loss-driven tumorigenesis linked to CRL4(DCAF1)-mediated inhibition of the hippo pathway kinases Lats1 and 2 in the nucleus.
    Li W; Cooper J; Zhou L; Yang C; Erdjument-Bromage H; Zagzag D; Snuderl M; Ladanyi M; Hanemann CO; Zhou P; Karajannis MA; Giancotti FG
    Cancer Cell; 2014 Jul; 26(1):48-60. PubMed ID: 25026211
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ischemia-inhibited ferric chelate reductase 1 improves ferroptosis-mediated intestinal ischemia injury via Hippo signaling.
    Liang P; Xie W; Wang X; Du Z; Zheng C; Zhao H; Wang Z; Ji Z
    Int Immunopharmacol; 2024 May; 132():111900. PubMed ID: 38531200
    [TBL] [Abstract][Full Text] [Related]  

  • 8. YAP/TAZ Inhibition Induces Metabolic and Signaling Rewiring Resulting in Targetable Vulnerabilities in NF2-Deficient Tumor Cells.
    White SM; Avantaggiati ML; Nemazanyy I; Di Poto C; Yang Y; Pende M; Gibney GT; Ressom HW; Field J; Atkins MB; Yi C
    Dev Cell; 2019 May; 49(3):425-443.e9. PubMed ID: 31063758
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hippo pathway gene mutations in malignant mesothelioma: revealed by RNA and targeted exon sequencing.
    Miyanaga A; Masuda M; Tsuta K; Kawasaki K; Nakamura Y; Sakuma T; Asamura H; Gemma A; Yamada T
    J Thorac Oncol; 2015 May; 10(5):844-851. PubMed ID: 25902174
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Critical roles of phosphoinositides and NF2 in Hippo pathway regulation.
    Hong AW; Meng Z; Plouffe SW; Lin Z; Zhang M; Guan KL
    Genes Dev; 2020 Apr; 34(7-8):511-525. PubMed ID: 32115406
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MEF2C silencing downregulates NF2 and E-cadherin and enhances Erastin-induced ferroptosis in meningioma.
    Bao Z; Hua L; Ye Y; Wang D; Li C; Xie Q; Wakimoto H; Gong Y; Ji J
    Neuro Oncol; 2021 Dec; 23(12):2014-2027. PubMed ID: 33984142
    [TBL] [Abstract][Full Text] [Related]  

  • 12. YAP/TAZ activation predicts clinical outcomes in mesothelioma and is conserved in in vitro model of driver mutations.
    Cunningham R; Jia S; Purohit K; Salem O; Hui NS; Lin Y; Carragher NO; Hansen CG
    Clin Transl Med; 2023 Feb; 13(2):e1190. PubMed ID: 36740402
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Hippo pathway member Nf2 is required for inner cell mass specification.
    Cockburn K; Biechele S; Garner J; Rossant J
    Curr Biol; 2013 Jul; 23(13):1195-201. PubMed ID: 23791728
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunohistochemistry for NF2, LATS1/2, and YAP/TAZ Fails to Separate Benign From Malignant Mesothelial Proliferations.
    Sheffield BS; Lorette J; Shen Y; Marra MA; Churg A
    Arch Pathol Lab Med; 2016 May; 140(5):391. PubMed ID: 27128293
    [No Abstract]   [Full Text] [Related]  

  • 15. Synergistic effect of PAK and Hippo pathway inhibitor combination in NF2-deficient Schwannoma.
    Benton D; Yee Chow H; Karchugina S; Chernoff J
    PLoS One; 2024; 19(7):e0305121. PubMed ID: 39083549
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NF2/Merlin Inactivation and Potential Therapeutic Targets in Mesothelioma.
    Sato T; Sekido Y
    Int J Mol Sci; 2018 Mar; 19(4):. PubMed ID: 29587439
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intercalated disc protein Xinβ is required for Hippo-YAP signaling in the heart.
    Guo H; Lu YW; Lin Z; Huang ZP; Liu J; Wang Y; Seok HY; Hu X; Ma Q; Li K; Kyselovic J; Wang Q; Lin JL; Lin JJ; Cowan DB; Naya F; Chen Y; Pu WT; Wang DZ
    Nat Commun; 2020 Sep; 11(1):4666. PubMed ID: 32938943
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A YAP/TAZ-induced feedback mechanism regulates Hippo pathway homeostasis.
    Moroishi T; Park HW; Qin B; Chen Q; Meng Z; Plouffe SW; Taniguchi K; Yu FX; Karin M; Pan D; Guan KL
    Genes Dev; 2015 Jun; 29(12):1271-84. PubMed ID: 26109050
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined Inhibition of NEDD8-Activating Enzyme and mTOR Suppresses
    Cooper J; Xu Q; Zhou L; Pavlovic M; Ojeda V; Moulick K; de Stanchina E; Poirier JT; Zauderer M; Rudin CM; Karajannis MA; Hanemann CO; Giancotti FG
    Mol Cancer Ther; 2017 Aug; 16(8):1693-1704. PubMed ID: 28468780
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The tumor suppressor NF2 modulates TEAD4 stability and activity in Hippo signaling via direct interaction.
    Wu M; Hu L; He L; Yuan L; Yang L; Zhao B; Zhang L; He X
    J Biol Chem; 2024 May; 300(5):107212. PubMed ID: 38522513
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 139.